Meningitis is caused by inflammation of the meninges- the outer membranes that cover the brain and spinal cord.
Viral meningitis is more common than bacterial meningitis, but all cases should be treated as bacterial until proven otherwise, as bacterial meningitis has a high mortality
Meningitis can be caused by bacteria, viruses, fungi, or be non-infective (secondary to some cancers including leukaemia and lymphoma, autoimmune diseases or drugs).
Young age is the most significant risk factor. Other risk factors include winter season, asplenia, immunocompromise, organ dysfunction, smoking and overcrowding
Bacterial meningitis:
Most common in infants, with a second incidence peak in teenagers and young adults
Transmitted via droplet spread and usually requires frequent or prolonged close contact
Most common bacterial organisms in neonates:
Most common = Streptococcus agalactiae (group B strep)
Escherichia coli
Streptococcus pneumoniae
Listeria monocytogenes
Most common bacterial organisms in babies over 3 months, children and adults:
Neisseria meningitidis (in 11-17 year olds)
Streptococcus pneumoniae (most common in all other ages)
Haemophilus influenzae type b
Meningococcal disease:
Bacterial meningitis causes by Neisseria meningitides
Meningococcal sepsis (causes classical rash)
Or a combination of both
Pneumococcal disease refers to disease caused by invasive Streptococcus pneumoniae:
Pneumonia
Meningitis
Sepsis
Vaccines are available for meningococcal subgroups A, B, C, W and Y, Hib and 13 serotypes of pneumococcus
Aseptic meningitis:
CSF has white blood cells on microscopy but the gram stain is negative and no bacteria are cultures on standard media
Viral meningitis - accounts for over half of all cases
Fungal meningitis
Atypical bacterial meningitis - TB, syphilis and Lyme disease
Most common viral meningitis pathogens:
Enteroviruses - echovirus and coxsackievirus
Others - mumps, HSV, herpes zoster, HIV, measles and influenza
Classically described as the triad of fever, neck stiffness and altered mental state; in reality, this picture is only seen in 44% of adults with bacterial meningitis and is even less specific in children.
Early symptoms and signs:
often vague and non-specific
Fever, headache, nausea/vomiting, lethargy
Later, more specific signs:
Neck stiffness or back rigidity
Kernig's sign
Brudzinski's sign
Non blanching rash (meningococcal disease)- petechiae or purpura
Photophobia
leg pain
Mottled skin
Altered mental state
Prolonged CRT
Shock
Neurological symptoms - seizures, paresis
Kernig's sign = pain and resistance on passive knee extension with hips fully flexed
Brudzinski's sign = knees and hips flex on bending the head forward
Bedside investigations:
Vital signs - signs of sepsis
Blood sugar - always required if an altered mental state is present
Lab investigations:
U&Es
CRP
FBC
Clotting studies - especially if petechial rash or sepsis
Blood cultures
Blood gases
Meningococcal PCR
CT head is sometimes performed if there are focal neurological deficits
Cannot exclude raised intracranial pressure
Cerebrospinal fluid (CSF) culture is the gold standard investigation for diagnosing bacterial meningitis, and 90% of acute bacterial meningitis cases have CSF WBC >100 cells/ microlitre
If possible, lumbar puncture should be performed within the hour before antibiotic treatment is commenced. If performing an LP will delay antibiotic treatment longer than this hour, antibiotics should be given and the LP performed later.
LP contraindications:
Raised ICP
Shock
Extensive spreading purpura
Convulsions (until stabilised)
Coagulation abnormalities
CSF is analysed for cell count (to count and identify the WBCs), gram stain (to identify bacteria), glucose, protein, lactate and culture. Other tests include bacterial and viral PCRs.
It is important to take a blood glucose level alongside (ideally just before) the LP so the ‘paired’ CSF and blood samples can be analysed
Treatment of any complications - metabolic disturbances, raised ICP and seizures
Meningitis is a notifiable disease and therefore needs to be reported to Public Health England
Initially, all cases of suspected meningitis should be treated as bacterial until proven otherwise
Further management will then be guided by the LP findings
Bacterial meningitis in primary care:
Urgent transfer to hospital
If there is suspected meningococcal sepsis then IM or IV benzylpenicillin can be given
Bacterial meningitis initial empirical therapy:
Children >3 months and adults - IV ceftriaxone
Children <3 months - IV cefotaxime + amoxicillin/ampicillin (covers for listeria)
IV dexamethasone is indicated in certain situations (i.e. children >3 months with bacteria on gram stain, frankly purulent CSF or CSF WBC >1000 cells/ microlitre)
For confirmed meningococcal disease, prophylactic antibiotics should be given to close contacts within 24 hours (usually ciprofloxacin or rifampicin)
Viral meningitis treatment:
No specific treatment, supportive management only
If there are concerns about encephalitis, IV aciclovir is used (the treatment for herpes simplex encephalitis)
Pneumococcal meningitis is associated with a poorer outcome than meningitis caused by Neisseria meningitidis or Haemophilus influenzae type b (Hib)
Acute complications of meningitis:
Sepsis
Septic shock
Disseminated intravascular coagulation
Cerebral oedema
Coma
Raised ICP
Subdural effusions
SIADH
Peripheral gangrene
Death
30–50% of survivors of acute bacterial meningitis experience permanent neurological sequelae
Common long term bacterial meningitis complications: